LEAP THERAPEUTICS
Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
LEAP THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2011-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.leaptx.com
Total Employee:
11+
Status:
Active
Contact:
(617)714-0360
Email Addresses:
[email protected]
Total Funding:
226.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Actimed Therapeutics
Actimed Therapeutics is a clinical stage biopharmaceutical company.
Avalo Therapeutics
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Caladrius Biosciences
Caladrius Biosciences is a clinical-stage biopharmaceutical company.
Cassava Sciences
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience.
Chromis Therapeutics
Chromis Therapeutics, Inc. (Chromis) is a San Diego-based biopharmaceutical company
Cloudbreak Therapeutics
Cloudbreak Therapeutics is a clinical stage biotechnology company
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cycle Pharmaceuticals
Cycle Pharmaceuticals is a pioneering pharmaceutical company.
Eikonoklastes Therapeutics
Eikonoklastes Therapeutics is a preclinical-stage biopharmaceutical company developing next-generation tissue factor (TF) immunotherapies.
Eirion Therapeutics
Eirion Therapeutics is a clinical-stage biopharmaceutical company that is developing next-generation prescription products.
Exvastat
Exvastat is an innovative, preclinical-stage pharmaceutical company.
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
Halia Therapeutics
Halia is a preclinical-stage biopharmaceutical company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Nano Cures
Nano Cures is clinical-stage biotechnology and infectious disease immunity platform company.
Osmotica Pharmaceutical
Osmotica Pharmaceutical is a global specialty pharmaceutical company.
Oxeia Biopharmaceuticals
Oxeia Biopharmaceuticals is a clinical stage biotech company.
Promontory Therapeutics
Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.
Aralez Pharmaceuticals
Aralez Pharmaceuticals is a global specialty pharmaceutical company.
Novelion Therapeutics
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company
Quell Therapeutics
Quell Therapeutics is a cell therapy company
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
SAB Biotherapeutics
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Saol Therapeutics
Saol Therapeutics is a biotech pharmaceutical company.
Sapient
Sapient is a full-service bioanalytical research organization.
Seaweed Solutions
Seaweed Solutions is a seaweed cultivator, innovator, and business development company.
SELLAS Life Sciences
SELLAS Life Sciences is a late-stage biopharmaceutical company.
Soleno Therapeutics
Soleno Therapeutics is a clinical-stage biopharmaceutical company.
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
UroGen Pharma
UroGen Pharma is a clinical-stage biopharmaceutical company focused on developing novel therapies.
VivaVision Biotech
VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.
Vyriad
Vyriad is a clinical stage biopharmaceutical company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Zentera Therapeutics
Zentera Therapeutics is a biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-08-29 | MacroCure | MacroCure acquired by Leap Therapeutics | N/A |
Investors List
BeiGene
BeiGene investment in Post-IPO Equity - Leap Therapeutics
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Leap Therapeutics
Eli Lilly & Company Foundation
Eli Lilly & Company Foundation investment in Post-IPO Equity - Leap Therapeutics
HealthCare Ventures
HealthCare Ventures investment in Venture Round - Leap Therapeutics
Torrey Pines Investment
Torrey Pines Investment investment in Seed Round - Leap Therapeutics
Official Site Inspections
http://www.leaptx.com Semrush global rank: 4.61 M Semrush visits lastest month: 2.19 K
- Host name: vps22613.dreamhostps.com
- IP address: 69.163.201.207
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "Leap Therapeutics"
Leap Therapeutics, Inc.
May 13, 2015 · Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a …See details»
About - Leap Therapeutics, Inc.
Is focused on developing targeted and immuno-oncology therapeutics. Leap’s most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 …See details»
Patients - Leap Therapeutics, Inc.
Leap Therapeutics is a patient focused company. We've all known someone important to us, a family member, friend, or co-worker, who has fought cancer. We admire the commitment of all of the patients who choose to enroll in …See details»
Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan ...
Jan 3, 2024 · Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. …See details»
Leap Therapeutics Reports Third Quarter 2024 Financial Results
Sep 30, 2024 · CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno …See details»
Leap Therapeutics - LinkedIn
Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.See details»
Leap Therapeutics to Participate at Piper Sandler 35th Annual ...
CAMBRIDGE, Mass., Nov. 21, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, …See details»
Leap Therapeutics Announces $40 Million Private Placement - PR …
Apr 11, 2024 · Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a …See details»
LPTX Stock Price Quote | Morningstar
Nov 20, 2024 · See the latest Leap Therapeutics Inc stock price (LPTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.See details»
Leap Therapeutics to Present at Ladenburg Thalmann 2021 Virtual ...
Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal …See details»
Leap Therapeutics, Inc. (LPTX) - Yahoo Finance
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the third quarter ended...See details»
Leap Therapeutics' Board of Directors Member Dr. Monica …
CAMBRIDGE, Mass., Aug. 12, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics …See details»
Leap Therapeutics (LPTX) Stock Price, News & Analysis - MarketBeat
Nov 20, 2024 · Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer.See details»
Leap Therapeutics Announces Reverse Stock Split
Jun 16, 2023 · CAMBRIDGE, Mass., June 20, 2023 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno …See details»
Leap Therapeutics to Participate at Upcoming Investor Conferences
Sep 5, 2023 · Leap Therapeutics (Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized …See details»
Leap Therapeutics - Overview, News & Similar companies
Jun 17, 2024 · Leap Therapeutics contact info: Phone number: (617) 714-0360 Website: www.leaptx.com What does Leap Therapeutics do? Leap Therapeutics (Nasdaq: LPTX) is …See details»
Leap Therapeutics Announces Closing of Public Offering of …
Jun 22, 2020 · Leap Therapeutics (Nasdaq:LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a …See details»
Leap Therapeutics Reports Second Quarter 2021 Financial Results …
CAMBRIDGE, Mass., Aug. 13, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX ), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, …See details»
RESOURCES AND ACTIVITIES OF LEAP TEXAS - AHA
LEAP stands for “Liberal Education and America’s Promise.” Initiative of the Association of American Colleges & Universities (AACU). One outgrowth of LEAP has been the development …See details»
Leap Therapeutics Reports Third Quarter 2021 Financial Results
Sep 30, 2021 · CAMBRIDGE, Mass., Nov. 12, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno …See details»